Next, in the older patient groups (> = 55 years), a low Sp1 level compared to a high Sp1 level was found to be related to a slightly poorer prognosis in women (HR = 2.882), but not in men (HR = 0.848), with late-stage lung cancer (Fig. 2, middle panel). Here, SP1 is linked to lung carcinoma.